🌍 Strides Pharma & Incepta Launch World’s First WHO-Approved Generic Injectable Contraceptive in Africa

🔹 Key Development: Strides Pharma Science Ltd., in partnership with Bangladesh-based Incepta Pharmaceuticals, has launched the world’s first WHO-prequalified generic version of subcutaneous depot medroxyprogesterone acetate (DMPA-SC) — a three-month injectable contraceptive. The product, branded Medogen SubQ, will be rolled out across Africa. 🔹 About Medogen SubQ: A long-acting contraceptive that can be self-administered or given by healthcare workers. Offers discreet, convenient, and affordable family planning options for women, particularly in underserved regions. Expected to enhance access to modern contraception across low- and middle-income countries. 🔹 Global Impact: The WHO prequalification, achieved with support from the Gates Foundation and Children’s Investment Fund Foundation (CIFF), breaks the single-source supply chain for DMPA-SC, enabling competitive pricing and broader distribution. Addresses a critical gap — over 250 million women globally still lack access to modern contraceptives. 🔹 Strategic Significance: Strengthens Strides’ women’s health portfolio in Africa, which already includes brands like Vitafer and L-Gest. Aligns with Strides’ “in Africa for Africa” strategy and its focus on impactful public health collaborations. 🔹 Leadership Comments: Aditya Kumar, Executive Director, Strides: “By bringing the WHO-prequalified product to Africa, we aim to expand choice and access for women, enabling them to take greater control of their reproductive health.” Abdul Muktadir, Chairman & MD, Incepta: “The WHO prequalification reinforces our commitment to global access and public health.” 🔹 About Strides Pharma: Operates in 100+ countries, focusing on complex generics, with manufacturing units in India, Italy, Kenya, and the U.S. #StridesPharma #InceptaPharma #MedogenSubQ #WHO #WomenHealth #Africa #ContraceptiveAccess #GatesFoundation #CIFF #PublicHealth #GenericMedicines #GlobalHealthcare #PharmaNews